CompuGroup Medical SE: Release of a capital market information

DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback CompuGroup Medical SE: Release of a capital market information 23.09.2019 / 15:17 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 1st Interim Announcement CompuGroup Medical SE / Share Buyback   Koblenz, September 23, 2019 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 1st Interim Announcement In the period from September 18, 2019, up to and including September 20, 2019, CompuGroup Medical SE has bought back a total of 46,652 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of September 17, 2019, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on September 18, 2019. The overall volume of the shares bought back daily in the period from September 18, 2019, up to and including September 20, 2019, and the daily volume-weighted average stock market prices of the shares are as follows: Date Overall volume of shares bought back (number) Volume-weighted average stock market price (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) September 18, 2019 23,415 52.0516 September 19, 2019 10,000 53.4988 September 20, 2019 13,237 54.6374                   In total: 46,652 53.0955   The total number of shares which have been bought back so far by CompuGroup Medical SE since September 18, 2019, up to and including September 20, 2019, within the framework of the share buyback program thus amounts to 46,652 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, September 23, 2019 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 23.09.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

878183  23.09.2019